2007

December

• Recall of ULTIVA (remifentanil hydrochloride) 1 mg vials due to potential for overdose
  • For Health Professionals
  • Abbott Laboratories Limited
    Date: 2007-12-21
• New warnings regarding ALERTEC (modafinil) and serious rash, allergic reactions, and mental problems
  • For Health Professionals
  • For the Public
  • Shire Canada Inc.
    Date: 2007-12-21

November

• Important Safety Information and availability of Trasylol (aprotinin)
  • Notice to Hospitals
  • Bayer Inc.
    Date: 2007-11-26
• New restrictions on the use of rosiglitazone products due to cardiac safety concerns (Avandia, Avandamet, Avandaryl)
  • For Health Professionals
  • For the Public
  • GlaxoSmithKline Inc
    Date: 2007-11-06

October

• Important Safety Information on Abbott Diabetes Care Precision Xtra
  • For Health Professionals
  • For the Public
  • Abbott Diabetes Care
    Date: 2007-10-29
• Urgent Medical Device Information on Medtronic Sprint Fidelis Lead Recall and Patient Management Recommendations
  • For Health Professionals
  • Medtronic of Canada Ltd.
    Date: 2007-10-25
• Important Safety Information on Colleague Volumetric Infusion Pumps
  • For Health Professionals
  • Baxter Corporation
    Date: 2007-10-23
• Important safety information on Definity (Perflutren Injectable Suspension)
  • For Health Professionals
  • Bristol-Myers Squibb Canada
    Date: 2007-10-19
• Important Safety Information on IRESSA (gefitinib)
  • For Health Professionals
  • AstraZeneca Canada Inc.
    Date: 2007-10-11
• Withdrawal of Market Authorization for Prexige (lumiracoxib)
  • For Health Professionals
  • For the Public
  • Novartis Pharmaceuticals Canada Inc.
    Date: 2007-10-05

September

• Important Safety Information on Sodium Phosphates Injection
  • Notice to Hospitals
  • Pharmaceutical Partners of Canada
    Date: 2007-09-27
• Safety Alert Notification for IV Administration Sets
  • For Health Professionals
  • Cardinal Health
    Date: 2007-09-17
• Important Safety Information on VIRACEPT (nelfinavir mesylate)
  • For Health Professionals
  • For the Public
  • Pfizer Canada Inc.
    Date: 2007-09-10
• Important Safety Information on KETEK (telithromycin)
  • For Health Professionals
  • For the Public
  • sanofi-aventis Canada Inc.
    Date: 2007-09-05

August

• Important Safety Information on THELIN (sitaxsentan sodium)
  • For Health Professionals
  • Encysive Canada, Inc.
    Date: 2007-08-23
• Cease Sale of Permax (pergolide mesylate) in Canada as of August 30, 2007
  • For Health Professionals
  • For the Public
  • Eli Lilly Canada Inc.
    Date: 2007-08-16
• Important Safety Information on RITUXAN (rituximab)
  • For Health Professionals
  • For the Public
  • Hoffmann-La Roche Limited
    Date: 2007-08-13
• Important Safety Information on Medtronic MiniMed Paradigm Insulin Infusion Pump
  • For Health Professionals
  • For the public
  • Medtronic of Canada Ltd.
    Date: 2007-08-13
• Important Product information on the Colleague Volumetric Infusion Pumps
  • For Health Professionals
  • Baxter Corporation
    Date: 2007-08-10
• Important Safety Information on Xylocaine (Lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL): Update
  • Notice to Hospitals
  • AstraZeneca Canada Inc.
    Date: 2007-08-07

July

• Urgent: Product Safety and Recall Notification regarding Smiths Medical CADD Medication Cassette Reservoirs
  • For Health Professionals
  • For The Public
  • Smiths Medical Canada Ltd.
    Date: 2007-07-25

June

• Important Safety Information on FLUOTIC (sodium fluoride) 20 mg tablets
  • For Health Professionals
  • sanofi-aventis Canada Inc
    Date: 2007-06-27
• Health Canada Endorsed Important Safety Information on Sensipar (cinacalcet hydrochloride)
  • For Health Professionals
  • For the Public
  • Amgen Canada Inc.
    Date: 2007-06-27
• VENTOLIN I.M. injection and VENTOLIN I.V. infusion solution for pregnant women & labour and delivery
  • Notice to Hospitals
  • GlaxoSmithKline Inc.
    Date: 2007-06-15
• Association of AVASTIN (bevacizumab) with tracheo-esophageal fistula
  • For Health Professionals
  • For the Public
  • Hoffman-La Roche Ltd.
    Date: 2007-06-12
• Voluntary recall of FRAXIPARINE graduated syringes, 0.6 mL and FRAXIPARINE FORTE graduated syringes, 0.8 mL
  • For Health Professionals
  • GlaxoSmithKline Inc.
    Date: 2007-06-08
• Cardiac safety of Avandia (rosiglitazone maleate)
  • For Health Professionals
  • For the Public (2007-05-30)
  • GlaxoSmithKline Inc.
    Date: 2007-06-01

May

• Safety Information on Bone Cements Used in Vertebroplasty and Kyphoplasty Procedures
  • Notice to Hospitals
    Date: 2007-05-30
• Important safety information concerning OneTouch Ultra Test Strips
  • For Health Professionals
  • For the Public
  • LifeScan Canada Ltd.
    Date: 2007-05-23
• Voluntary Type 1 Recall of Depakene (valproic acid) 500-mg Enteric-Coated Capsules in Canada
  • For Health Professionals (2007-05-16)
  • For the Public
    • Public Communication
    • Health Canada Warning (2007-05-14)
  • Abbott Laboratories, Limited
    Date: 2007-05-18
• Voluntary Type 1 Recall of ratio-Valproic (valproic acid) 500-mg Enteric-Coated Capsules in Canada
  • For Health Professionals
  • For the Public
    • Health Canada Warning (2007-05-14)
  • ratiopharm inc.
    Date: 2007-05-17
• Information Regarding Myozyme (alglucosidase alfa)
  • For Health Professionals
  • Genzyme Canada Inc.
    Date: 2007-05-17
• Urgent Medical Device Information - Subset of Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators
  • For Health Professionals
  • Boston Scientific
    Date: 2007-05-09
• Association between Long-Term Treatment with Actos (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
  • For Health Professionals
  • For the Public
  • Eli Lilly Canada Inc.
    Date: 2007-05-07

April

• Important safety information and new prescribing information for the erythropoiesis-stimulating agents (ESAs), Aranesp (darbepoietin alfa) and Eprex (epoetin alfa)
  • For Health Professionals
  • For the Public
  • Amgen Canada and Janssen-Ortho, Inc.
    Date: 2007-04-20
• Urgent Medical Device Safety Information and Corrective Action - DDU-100 Series Automatic External Defibrillators
  • For Health Professionals
  • For the Public
  • Defibtech, LLC
    Date: 2007-04-12
• Voluntary suspension of sales of Zelnorm due to cardiovascular ischemic events
  • For Health Professionals
  • For the Public
  • Novartis Pharmaceuticals Canada Inc.
    Date: 2007-04-02

March

• Association of Trasylol (aprotinin) with hypersensitivity reactions and renal dysfunction
  • Notice to Hospitals
  • For the Public
  • Bayer Inc.
    Date: 2007-03-30
• Association of acute renal failure (severe kidney problems) and reports of cytopenias (low blood cell counts) with Exjade (deferasirox)
  • For Health Professionals
  • For the Public
  • Novartis Pharmaceuticals Canada Inc.
    Date: 2007-03-19
• Important Safety Information on the Use of Waist and Torso Patient Restraints
  • Notice to Hospitals
    Date: 2007-03-19
• Association of Omniscan (Gadodiamide) and Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD)
  • For Health Professionals
  • For the Public
  • GE Healthcare Canada
    Date: 2007-03-13
• Association of gadolinium-containing contrast agents and Nephrogenic Systemic Fibrosis /Nephrogenic Fibrosing Dermopathy (NSF/NFD)
  • Notice to Hospitals
  • For the Public
    Date: 2007-03-13
• Important information concerning unpredictable events in medical equipment due to Daylight Savings Time change
  • For Health Professionals
  • For the Public
    • Health Canada Information Update
    • United States Advice for Patients
      Date: 2007-03-07
• Important Safety Information on Pinel Rotating Waist Restraint
  • Notice to Hospitals
  • Pinel Medical Inc.
    Date: 2007-03-05

February

• Important safety information on rosiglitazone-containing products: Avandia, Avandamet and Avandaryl
  • For Health Professionals
  • For the Public
  • GlaxoSmithKline Inc. (GSK)
    Date: 2007-02-28
• Information Regarding Baraclude (entecavir)
  • For Health Professionals
  • For the Public
  • Bristol-Myers Squibb Canada
    Date: 2007-02-21
• Important Safety Information on Bone Cements Used in Vertebroplasty and Kyphoplasty Procedures
  • Notice to Hospitals
    Date: 2007-02-09